Literature DB >> 1721492

The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.

A Crowe1, H Ksiezak-Reding, W K Liu, D W Dickson, S H Yen.   

Abstract

Antibody (Ab) E-1 was raised to the amino terminus (19 to 33 amino acid residues) of human tau. It recognized Alzheimer's disease proteins A68 (MW 60, 64, 68 kd), labeled paired helical filaments, and had no reactivity with tau from rat, mouse, and bovine brains. The results indicate that the N terminus of tau is incorporated in A68 proteins and paired helical filaments and that human tau proteins contain species-specific amino acid sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721492      PMCID: PMC1886469     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY.

Authors:  M KIDD
Journal:  Brain       Date:  1964-06       Impact factor: 13.501

2.  Straight and paired helical filaments in Alzheimer disease have a common structural unit.

Authors:  R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  Alz-50 recognizes a phosphorylated epitope of tau protein.

Authors:  K Uéda; E Masliah; T Saitoh; S L Bakalis; H Scoble; K S Kosik
Journal:  J Neurosci       Date:  1990-10       Impact factor: 6.167

6.  Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads.

Authors:  M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Lab Invest       Date:  1991-03       Impact factor: 5.662

7.  Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains.

Authors:  A Himmler; D Drechsel; M W Kirschner; D W Martin
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  Structural characterization of the core of the paired helical filament of Alzheimer disease.

Authors:  C M Wischik; M Novak; P C Edwards; A Klug; W Tichelaar; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Epitopes that span the tau molecule are shared with paired helical filaments.

Authors:  K S Kosik; L D Orecchio; L Binder; J Q Trojanowski; V M Lee; G Lee
Journal:  Neuron       Date:  1988-11       Impact factor: 17.173

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  15 in total

1.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB.

Authors:  D W Dickson; W K Liu; Y Kress; J Ku; O DeJesus; S H Yen
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Proteasome degradation of brain cytosolic tau in Alzheimer's disease.

Authors:  Samuel S Yen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

4.  Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat.

Authors:  Ronald L Klein; Robert D Dayton; Wen-Lang Lin; Dennis W Dickson
Journal:  Neurobiol Dis       Date:  2005-10       Impact factor: 5.996

5.  Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2.

Authors:  Matthew Hamm; Rachel Bailey; Gerry Shaw; Shu-Hui Yen; Jada Lewis; Benoit I Giasson
Journal:  J Neurosci Res       Date:  2015-06-30       Impact factor: 4.164

6.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.

Authors:  Masaki Ikeda; Mikio Shoji; Toshitaka Kawarai; Takeshi Kawarabayashi; Etsuro Matsubara; Tetsuro Murakami; Atsushi Sasaki; Yasushi Tomidokoro; Yasushi Ikarashi; Hisashi Kuribara; Koichi Ishiguro; Masato Hasegawa; Shu-Hui Yen; M Azhar Chishti; Yasuo Harigaya; Koji Abe; Koichi Okamoto; Peter St George-Hyslop; David Westaway
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

7.  An N-terminal motif unique to primate tau enables differential protein-protein interactions.

Authors:  Kristie Stefanoska; Alexander Volkerling; Josefine Bertz; Anne Poljak; Yazi D Ke; Lars M Ittner; Arne Ittner
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

8.  Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites.

Authors:  W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

9.  Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer.

Authors:  Ronald L Klein; Robert D Dayton; Cynthia G Diaczynsky; David B Wang
Journal:  Neurobiol Aging       Date:  2009-01-19       Impact factor: 4.673

10.  Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.

Authors:  Wen-Lang Lin; Jada Lewis; Shu-Hui Yen; Michael Hutton; Dennis W Dickson
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.